Find a Tender · Contract

Branded and Biosimilar Ophthalmology

A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) via Find a Tender.

Find a TenderContract
Award value
£146.6m
Tender value
7
Suppliers
8
Awards
2
Notices
Contract
Stage

Overview

Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

Key details

Source
Find a Tender
Lifecycle stage
Contract
Status
active
CPV classification
33600000 — Pharmaceutical products
Currency
GBP
Total award value
Tender value
£146,579,216
First published
6 Aug 2025
Last updated
24 Nov 2025
View the original notice

Awards

8 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Bayer Plcactive
Mercury Pharmaceuticals Limited02619880active
Teva UK Ltd00302461active
Celltrion Healthcare United Kingdom Limited11685363active
MD Biologicsactive
Sandoz01547204active
Biogen Idec Ltd01497267active
Teva UK Ltd00302461active

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Tender noticeBranded and Biosimilar Ophthalmology
  2. Award,contractBranded and Biosimilar Ophthalmology

All suppliers

Frameworks & programmes

More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

FAQs about this procurement

Who is the buyer for "Branded and Biosimilar Ophthalmology"?

Branded and Biosimilar Ophthalmology is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) via Find a Tender.

Has "Branded and Biosimilar Ophthalmology" been awarded?

Yes — 8 awards are recorded, with a reported total value of £146,579,216. The current lifecycle stage is "Contract".

Which suppliers are involved in "Branded and Biosimilar Ophthalmology"?

7 suppliers are linked: Bayer Plc, Mercury Pharmaceuticals Limited, Teva UK Ltd, Celltrion Healthcare United Kingdom Limited, MD Biologics, Sandoz, Biogen Idec Ltd.

What is "Branded and Biosimilar Ophthalmology" worth?

The reported tender value is £146,579,216.

When was "Branded and Biosimilar Ophthalmology" published?

It was first published on 6 Aug 2025 and last updated on 24 Nov 2025, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable